Calmare Therapeutics Inc. (CTTC) to Present at National Investment Banking Association (NIBA) Conference
Calmare Therapeutics (OTC: CTTC) studies, commercializes and creates medical devices that help mitigate chronic and neuropathic pain. The company's main product - the Calmare® Pain Therapy Device - is the first device to effectively treat chronic and neuropathic pain without being invasive and without causing addiction. Calmare is granted the exclusive right by the U.S. Food & Drug Administration to further develop, research and sell this medical device within the United States. However, the devices offered by Calmare are used by medical practices around the globe and are commonly used in U.S. military hospitals and clinics. For more information, visit…







